Literature DB >> 11135069

Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study.

J M Fasano1, S R Khan.   

Abstract

BACKGROUND: Since urine spends only a few minutes in the renal tubules and has a low supersaturation with respect to calcium oxalate (CaOx), nucleation of CaOx crystals in the kidneys is most probably heterogeneous. We have proposed that membranes of cellular degradation products are the main substrate for crystal nucleation. The purpose of our study was to determine the site of membrane-mediated crystal nucleation within the renal tubules and the required lag time, factors that determine whether crystallization results in crystalluria or nephrolithiasis.
METHODS: Nucleation of CaOx was allowed to occur in five different artificial urine solutions with ionic concentrations simulating urine in proximal tubules (PTs), descending (DLH) and ascending (ALH) limbs of the loop of Henle, distal tubules (DTs), and collecting ducts (CDs). A constant composition crystallization system was used. Experiments were run for two hours with or without the renal tubular brush border membrane (BBM) vesicles.
RESULTS: The addition of BBM significantly reduced the nucleation lag time and increased the rate of crystallization. The average nucleation lag time decreased from 84.6 +/- 43.4 minutes to 24.5 +/- 19 minutes in PTs, from 143.6 +/- 29 to 70.2 +/- 53.4 minutes in DLH, from 17.6 +/- 8.6 minutes to 0.625 +/- 0.65 minutes in DTs and from 9.54 +/- 3. 03 minutes to 0.625 +/- 0.65 minutes in CDs. There was no nucleation in the ALH solution without BBM for two hours. CaOx dihydrate (COD) was common in most solutions. Calcium phosphate (CaP) also nucleated in the DLH and CD solutions.
CONCLUSIONS: In the absence of membrane vesicles, there was no crystallization in any of the solutions within the time urine spends in the renal tubules. As a result, homogeneous nucleation of crystals anywhere within the nephron appears unlikely. However, BBM-supported nucleation is possible in the DTs as well as CDs. A high crystallization rate in CDs would promote rapid crystal growth and aggregation, resulting in crystal retention within the kidneys and development of nephrolithiasis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11135069     DOI: 10.1046/j.1523-1755.2001.00477.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  Lithogenic activity and clinical relevance of lipids extracted from urines and stones of nephrolithiasis patients.

Authors:  Chanchai Boonla; Phantip Youngjermchan; Somkiat Pumpaisanchai; Kriang Tungsanga; Piyaratana Tosukhowong
Journal:  Urol Res       Date:  2010-05-28

Review 2.  In vitro calcium oxalate crystallisation methods.

Authors:  John P Kavanagh
Journal:  Urol Res       Date:  2006-01-14

Review 3.  The role of calcium phosphate in the development of Randall's plaques.

Authors:  Hans-Göran Tiselius
Journal:  Urolithiasis       Date:  2013-08-21       Impact factor: 3.436

Review 4.  Hyperoxaluria-induced oxidative stress and antioxidants for renal protection.

Authors:  Saeed R Khan
Journal:  Urol Res       Date:  2005-11-15

5.  Urinary extracellular vesicle-associated MCP-1 and NGAL derived from specific nephron segments differ between calcium oxalate stone formers and controls.

Authors:  Robin S Chirackal; Muthuvel Jayachandran; Xiangling Wang; Samuel Edeh; Zejfa Haskic; Majuran Perinpam; Timothy M Halling; Ramila Mehta; Marcelino E Rivera; John C Lieske
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-28

6.  Association of Randall plaque with collagen fibers and membrane vesicles.

Authors:  Saeed R Khan; Douglas E Rodriguez; Laurie B Gower; Manoj Monga
Journal:  J Urol       Date:  2012-01-21       Impact factor: 7.450

7.  Renal tubular epithelial cell injury, apoptosis and inflammation are involved in melamine-related kidney stone formation.

Authors:  Xiuli Lu; Bing Gao; Youliang Wang; Zehui Liu; Takahiro Yasui; Ping Liu; Jian Liu; Newton Emmanuel; Qiwen Zhu; Chunling Xiao
Journal:  Urol Res       Date:  2012-09-28

8.  Development of a Kidney Calcification Inhibitor Employing Image-Based Profiling: A Proof-of-Concept Study.

Authors:  Anna Kletzmayr; Melina Bigler; Elita Montanari; Makoto Kuro-O; Hirosaka Hayashi; Mattias E Ivarsson; Jean-Christophe Leroux
Journal:  ACS Pharmacol Transl Sci       Date:  2020-11-23

9.  Reverse engineering the kidney: modelling calcium oxalate monohydrate crystallization in the nephron.

Authors:  A Borissova; G E Goltz; J P Kavanagh; T A Wilkins
Journal:  Med Biol Eng Comput       Date:  2010-04-28       Impact factor: 2.602

Review 10.  Herbal medicines in the management of urolithiasis: alternative or complementary?

Authors:  Veronika Butterweck; Saeed R Khan
Journal:  Planta Med       Date:  2009-05-14       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.